Axelrod L
Lancet. 1983 Apr 23;1(8330):904-6. doi: 10.1016/s0140-6736(83)91330-2.
Glucocorticoids have a permissive effect on vascular tone and blood pressure; they enhance vascular responsiveness to vasopressors such as catecholamines without necessarily having an effect when administered alone. This effect does not require central or systemic mediation. Prostacyclin (prostaglandin I2; PGI2), a potent vasodilator, is produced by the vascular endothelium, vascular smooth muscle cells, adipocytes, and other cells. PGI2 production by vascular endothelium and other cells is decreased by glucocorticoids. The hypothesis is proposed that the effect of glucocorticoids on vascular tone is mediated by inhibition of PGI2 production by vascular endothelium (possibly other cells also). The inhibition of PGI2 production by glucocorticoids may contribute to the hypertension of Cushing's syndrome. Loss of this inhibitory effect in glucocorticoid deficiency states (eg, Addison's disease) may cause enhanced PGI2 production, which may contribute to the haemodynamic and gastrointestinal manifestations of these disorders.
糖皮质激素对血管张力和血压有允许作用;它们增强血管对血管加压药(如儿茶酚胺)的反应性,单独给药时不一定有作用。这种作用不需要中枢或全身介导。前列环素(前列腺素I2;PGI2)是一种强效血管扩张剂,由血管内皮细胞、血管平滑肌细胞、脂肪细胞和其他细胞产生。糖皮质激素会降低血管内皮细胞和其他细胞产生PGI2的能力。提出的假说是,糖皮质激素对血管张力的作用是通过抑制血管内皮细胞(可能其他细胞也一样)产生PGI2来介导的。糖皮质激素对PGI2产生的抑制作用可能导致库欣综合征的高血压。在糖皮质激素缺乏状态(如艾迪生病)下这种抑制作用的丧失可能导致PGI2产生增加,这可能导致这些疾病的血流动力学和胃肠道表现。